ALYPSIS INC. - Suchergebnisse

Europäische Union - Kroatisch - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Europäische Union - Kroatisch - EMA (European Medicines Agency)

neofordex

theravia - deksametazon - multipli mijelom - kortikosteroidi za sistemsku upotrebu - liječenje multiplih mijeloma.

Montenegro - Kroatisch - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

able haemodialysis catheter kit

"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - medicinska sredstva za jednokratnu upotrebu

Montenegro - Kroatisch - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

tubing sets for hemodialysis novaline model: bl 105

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - medicinska sredstva za jednokratnu upotrebu

Europäische Union - Kroatisch - EMA (European Medicines Agency)

ontilyv

bial portela & companhia s.a. - opicapone - parkinsonova bolest - antiparkinsonski lijekovi - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.